Literature DB >> 7724728

Radiation-induced DNA double-strand breaks produced in histone-depleted tumor cell nuclei measured using the neutral comet assay.

P L Olive1, J P Banáth.   

Abstract

Removal of histones and other nuclear proteins greatly enhances the sensitivity of mammalian cells to DNA damage by ionizing radiation. We examined the possibility that the ease of dissociation of histones, or the association of other nuclear proteins with DNA, may differ between radioresistant and sensitive human tumor cells. Cells embedded in agarose were exposed to increasing salt concentrations prior to irradiation and examination using a microscopic gel electrophoresis method, the neutral comet assay. Induction of double-strand breaks increased by a factor of about 20 when cells of four human tumor cell lines, HT144 melanoma, HT29 adenocarcinoma, DU145 prostate carcinoma and U87 glioma, were exposed to 2 M NaCl prior to irradiation. Subtle differences in sensitivity to induction of double-strand breaks by radiation between cells of the four cell lines were also observed after extraction with 0.7-1.1 M NaCl; however, no correlation with radiosensitivity was apparent. While a significant number of histone and non-histone proteins are present after extraction with 1.2 M NaCl, these proteins apparently have only a minor influence on radiosensitivity. However, if they are allowed to remain with DNA during electrophoresis, about 15 times more strand breaks are required to produce a similar amount of DNA migration in both DU145 and HT144 cells. These results suggest that the association between proteins and DNA within the nucleus, as probed by extraction with sodium chloride, does not help to explain differences in intrinsic radiosensitivity among cells of these diverse tumor cell lines.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7724728

Source DB:  PubMed          Journal:  Radiat Res        ISSN: 0033-7587            Impact factor:   2.841


  6 in total

1.  Hdac3 is essential for the maintenance of chromatin structure and genome stability.

Authors:  Srividya Bhaskara; Sarah K Knutson; Guochun Jiang; Mahesh B Chandrasekharan; Andrew J Wilson; Siyuan Zheng; Ashwini Yenamandra; Kimberly Locke; Jia-Ling Yuan; Alyssa R Bonine-Summers; Christina E Wells; Jonathan F Kaiser; M Kay Washington; Zhongming Zhao; Florence F Wagner; Zu-Wen Sun; Fen Xia; Edward B Holson; Dineo Khabele; Scott W Hiebert
Journal:  Cancer Cell       Date:  2010-11-16       Impact factor: 31.743

2.  Single-cell gel electrophoresis (SCG)-A review and discussion.

Authors:  Y Lu; T Takeshita; K Morimoto
Journal:  Environ Health Prev Med       Date:  1997-07       Impact factor: 3.674

3.  Tumor necrosis factor alpha-induced apoptosis in cardiac myocytes. Involvement of the sphingolipid signaling cascade in cardiac cell death.

Authors:  K A Krown; M T Page; C Nguyen; D Zechner; V Gutierrez; K L Comstock; C C Glembotski; P J Quintana; R A Sabbadini
Journal:  J Clin Invest       Date:  1996-12-15       Impact factor: 14.808

4.  PKR inhibits the DNA damage response, and is associated with poor survival in AML and accelerated leukemia in NHD13 mice.

Authors:  Xiaodong Cheng; Michael Byrne; Kevin D Brown; Marina Y Konopleva; Steven M Kornblau; Richard L Bennett; W Stratford May
Journal:  Blood       Date:  2015-07-22       Impact factor: 22.113

5.  XAV939-mediated ARTD activity inhibition in human MB cell lines.

Authors:  Cristiano Renna; Roberta Salaroli; Claudia Cocchi; Giovanna Cenacchi
Journal:  PLoS One       Date:  2015-04-02       Impact factor: 3.240

6.  DNA damage and repair capacity in lymphocyte of chronic obstructive pulmonary diseases patients during physical exercise with oxygen supplementation.

Authors:  Andréa Lúcia Gonçalves da Silva; Thaís Evelyn Karnopp; Augusto Ferreira Weber; Cassia da Luz Goulart; Paloma de Borba Scheneiders; Dannuey Machado Cardoso; Lisiane Lisboa Carvalho; Joel Henrique Ellwanger; Lia Gonçalves Possuelo; Andréia Rosane de Moura Valim
Journal:  Multidiscip Respir Med       Date:  2016-12-14
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.